Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent

NCT02753231 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-11-29

No results posted yet for this study

Summary

The HEPAFIT Study aims to examine whether a 6-months physical education program has benefits on hepatic metabolism and cardiovascular health as well as on selected physical fitness and mental health outcomes among adolescent overweight/obese from Bogota, Colombia.

Conditions

  • Obesity
  • Metabolic Syndrome X
  • Lipid Metabolism Disorders
  • Body Composition, Beneficial
  • Mental Health Wellness 1

Interventions

BEHAVIORAL

Low physical activity program

Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

BEHAVIORAL

High physical activity program

Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

BEHAVIORAL

Low and High physical activity program

Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

BEHAVIORAL

Conventional physical activity program

One Physical Education sessions / week

Sponsors & Collaborators

  • Universidad de Santiago de Chile

    collaborator OTHER
  • Universidad de Granada

    collaborator OTHER
  • Universidad Pública de Navarra

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • University of Castilla-La Mancha

    collaborator OTHER
  • Universidad Santo Tomas

    lead OTHER

Principal Investigators

  • Robinson Ramirez Velez, Ph.D · Universidad del Rosario

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
11 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02753231 on ClinicalTrials.gov